PharmaShots | Incisive News in 3 Shots

Subscribe Now

RELAY Study

Eli Lilly Report Results of Cyramza (ramucirumab) in P-III RELAY Study for 1L Treatment of EGFR-Mutated Non-Small Cell Lung Cancer

Eli Lilly Report Results of Cyramza (ramucirumab) in P-III RELAY Study for 1L Treatment of EGFR-Mutated Non-Small Cell Lung Cancer

October 7, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us